By expenditures
| Name | Title | Type |
|---|---|---|
| Linda Nguyen | Vice President of Finance | Auditee |
| Aaron Crall | Principal | Auditee |
| Melissa Mitro | VP FINANCE AND ADMINISTRATION | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 331081 | 2024 | 2024-12-05 | Cliftonlarsonallen LLP | $3.35M |
| 299868 | 2023 | 2024-03-28 | Cliftonlarsonallen LLP | $5.92M |
| 28916 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $9.72M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 331081 | 2024 | 2024-12-05 | 1089562 | 2024-002 | Significant Deficiency | Yes | L |
| 331081 | 2024 | 2024-12-05 | 1089561 | 2024-001 | Significant Deficiency | Yes | L |
| 331081 | 2024 | 2024-12-05 | 513120 | 2024-002 | Significant Deficiency | Yes | L |
| 331081 | 2024 | 2024-12-05 | 513119 | 2024-001 | Significant Deficiency | Yes | L |
| 299868 | 2023 | 2024-03-28 | 964263 | 2023-005 | Significant Deficiency | - | L |
| 299868 | 2023 | 2024-03-28 | 964262 | 2023-005 | Significant Deficiency | - | L |
| 299868 | 2023 | 2024-03-28 | 964261 | 2023-004 | Significant Deficiency | - | N |
| 299868 | 2023 | 2024-03-28 | 964260 | 2023-003 | Significant Deficiency | Yes | N |
| 299868 | 2023 | 2024-03-28 | 964259 | 2023-003 | Significant Deficiency | Yes | N |
| 299868 | 2023 | 2024-03-28 | 964258 | 2023-003 | Significant Deficiency | Yes | N |
| 299868 | 2023 | 2024-03-28 | 964257 | 2023-002 | Material Weakness | Yes | N |
| 299868 | 2023 | 2024-03-28 | 387821 | 2023-005 | Significant Deficiency | - | L |
| 299868 | 2023 | 2024-03-28 | 387820 | 2023-005 | Significant Deficiency | - | L |
| 299868 | 2023 | 2024-03-28 | 387819 | 2023-004 | Significant Deficiency | - | N |
| 299868 | 2023 | 2024-03-28 | 387818 | 2023-003 | Significant Deficiency | Yes | N |
| 299868 | 2023 | 2024-03-28 | 387817 | 2023-003 | Significant Deficiency | Yes | N |
| 299868 | 2023 | 2024-03-28 | 387816 | 2023-003 | Significant Deficiency | Yes | N |
| 299868 | 2023 | 2024-03-28 | 387815 | 2023-002 | Material Weakness | Yes | N |
| 28916 | 2022 | 2023-03-30 | 614451 | 2022-007 | Significant Deficiency | Yes | L |
| 28916 | 2022 | 2023-03-30 | 614450 | 2022-005 | Significant Deficiency | - | E |
| 28916 | 2022 | 2023-03-30 | 614449 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 614448 | 2022-003 | Significant Deficiency | Yes | L |
| 28916 | 2022 | 2023-03-30 | 614447 | 2022-002 | Significant Deficiency | Yes | L |
| 28916 | 2022 | 2023-03-30 | 614446 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 614445 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 614444 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 614443 | 2022-006 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 38009 | 2022-007 | Significant Deficiency | Yes | L |
| 28916 | 2022 | 2023-03-30 | 38008 | 2022-005 | Significant Deficiency | - | E |
| 28916 | 2022 | 2023-03-30 | 38007 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 38006 | 2022-003 | Significant Deficiency | Yes | L |
| 28916 | 2022 | 2023-03-30 | 38005 | 2022-002 | Significant Deficiency | Yes | L |
| 28916 | 2022 | 2023-03-30 | 38004 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 38003 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 38002 | 2022-004 | Significant Deficiency | - | N |
| 28916 | 2022 | 2023-03-30 | 38001 | 2022-006 | Significant Deficiency | - | N |